Upcoming Events

Upcoming Events

Date	Event Details	Remind Me
Dec 5, 2019	Investor Breakfast 2019	Add to Outlook Add to Google Calendar
Jan 13, 2020	Biotech Showcase	Add to Outlook Add to Google Calendar

Press Releases View all

September 25, 2019

BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

September 25, 2019

BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

September 3, 2019

BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

Upcoming Events View all